Annovis Bio Inc (ANVS) Stock Analysis
Verdict: AVOID
Severe cash burn leaves ~9 months runway, forcing imminent share dilution that overshadows insider buying and clinical potential.
Investment score: 29/100
Analysis as of
Is Annovis Bio Inc stock worth reviewing? The TradeMates thesis
The TradeMates model designates ANVS as an AVOID due to severe cash burn (~9.1 months runway), historical share dilution of 226% over 5 years, and technical breakdown near 52-week lows ($1.10 USD).
7-factor investment score
- Valuation: 25/100 (weight 20%)
- Financial Health: 10/100 (weight 15%)
- Technical Momentum: 15/100 (weight 15%)
- Earnings Quality: 30/100 (weight 15%)
- Insider Sentiment: 70/100 (weight 10%)
- Analyst Consensus: 60/100 (weight 10%)
- Risk-Adjusted Return: 20/100 (weight 15%)
Annovis Bio Inc opportunities and risks
What speaks for ANVS
- Insiders are aggressively buying shares during the sell-off.
What speaks against ANVS
- Imminent capital raise and severe shareholder dilution.
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| ANVS | n/a | 0.0x | n/a | 0.0% | 0.0% | -91.0% |
| TIL | n/a | 0.0x | n/a | 0.0% | 0.0% | -47.2% |
| MCRB | n/a | 25.8x | n/a | 82.6% | -1192.9% | -105.7% |
| TVGN | n/a | 0.0x | n/a | 0.0% | 0.0% | -38.0% |
| HOWL | n/a | 2.3x | n/a | 86.4% | -164.8% | -63.2% |
| VICP | n/a | 0.0x | n/a | 0.0% | 0.0% | -0.0% |
| Peer median | n/a | 0.0x | n/a | 0.0% | 0.0% | -47.2% |
Frequently asked questions about Annovis Bio Inc (ANVS)
Is ANVS stock a good investment?
The TradeMates model rates Annovis Bio Inc as AVOID with an investment score of 29/100. The TradeMates model designates ANVS as an AVOID due to severe cash burn (~9.1 months runway), historical share dilution of 226% over 5 years, and technical breakdown near 52-week lows ($1.10 USD). This is algorithmic model output, not personal investment advice.
Is ANVS stock a buy?
The TradeMates model verdict for ANVS is AVOID with an investment score of 29/100. Treat this as a model signal to review, not a personal buy recommendation.